Casimersen is an investigational compound being developed by Sarepta Therapeutics to treat Duchenne muscular dystrophy (DMD) patients with mutations amenable to exon 45 skipping. 

Market Analysis and Insights: Global Casimersen Market
The global Casimersen market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Casimersen Scope and Market Size
The global Casimersen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Casimersen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Injection
Others

Segment by Application
Hospitals
Clinics
Others

The Casimersen market is analysed and market size information is provided by regions (countries). Segment by Application, the Casimersen market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Sarepta Therapeutics